Company overview

Fagron is committed to the personalization of health treatment to cover the individual patient’s need through Pharmaceutical Compounding & Sterile Outsourcing Services. Pharmaceutical Compounding allows pharmacists and prescribers to create medication that satisfies patients’ needs. Through our services towards personalization, we can extend the range of mass-produced medication and keep available medicaments that are no longer offered commercially in an affordable way for those who need them. Fagron was founded in the Netherlands in 1990 and is currently present in 35 countries worldwide enabling pharmacists, prescribers, hospitals, and industry to provide quality, safety, and service for their patients.Together we create the future of personalizing medicine.
Founded in 1990
Rotterdam, South Holland, NLD
2.5K employees (120 in marketing)

Salaries

Help build salary transparency at Fagron

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

4 open now

Headcount trend

Company growth over the last 12 months

Headcount +6.9% year over year

Funding

Total funding

$464.1M

Last raise

$225M

Post IPO Debt, 4 months ago

Funding history

Nov 2025

Post IPO Debt Fagron SA · $225M

Mar 2016

Post IPO Equity Fagron SA · $239.1M

Audience

Monthly website visitors
44.4K
Month over month+9.4%
Quarter over quarter-11.3%
Top sourceSearch (62.4%)
Ad budget per month$0.0
Average search rank44.4
Traffic source mix
Search
62.4%
Direct
28.3%
Referral
5.8%
Social
1.9%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

69.5K

12-mo growth

Monthly growth

+3.7%

News

Links